AU Patent

AU2862200A — Compositions, kits, apparatus, and methods for inhibiting cerebral neurovasculardisorders and muscular headaches

Assigned to Individual · Expires 2000-08-18 · 26y expired

What this patent protects

Patent listed against Elocon.

Drugs covered by this patent

Elocon (MOMETASONE FUROATE) · Merck & Co.

Patent Metadata

Patent number: AU2862200A
Jurisdiction: AU
Classification: —
Expires: 2000-08-18
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.